Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1977 1
1979 2
1980 1
1981 1
1982 1
1983 1
1988 1
1991 1
1992 1
1994 2
1995 1
1997 1
2000 1
2002 1
2005 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean malignim (89 results)?
Anti-malignin antibody evaluation: a possible challenge for cancer management.
Botti C, Martinetti A, Nerini-Molteni S, Ferrari L. Botti C, et al. Int J Biol Markers. 1997 Oct-Dec;12(4):141-7. doi: 10.1177/172460089701200401. Int J Biol Markers. 1997. PMID: 9582602 Review.
The availability of a non-invasive test which detects a blood molecule closely associated with the malignant transformation of the cells could be of help in the early detection of cancer. Malignin is a 10 kDa polypeptide located in the cytoplasmic and outer membranes of al …
The availability of a non-invasive test which detects a blood molecule closely associated with the malignant transformation of the cells cou …
Malignin antibody and early malignancy.
Bogoch S, Bogoch ES. Bogoch S, et al. Lancet. 1991 Apr 20;337(8747):977. doi: 10.1016/0140-6736(91)91609-x. Lancet. 1991. PMID: 1678055 No abstract available.
Anti-malignin antibody in serum and other tumor marker determinations in breast cancer.
Thornthwaite JT. Thornthwaite JT. Cancer Lett. 2000 Jan 1;148(1):39-48. doi: 10.1016/s0304-3835(99)00297-9. Cancer Lett. 2000. PMID: 10680591
In this study, 154 healthy volunteers and 76 patients were tested using the anti-malignin antibody in serum (AMAS) test. Of the 154 volunteers, three were AMAS positive. ...
In this study, 154 healthy volunteers and 76 patients were tested using the anti-malignin antibody in serum (AMAS) test. Of the 154 v …
Monoclonal anti-malignin antibodies.
Bogoch S, Bogoch ES, Tsung YK. Bogoch S, et al. Lancet. 1981 Jul 18;2(8238):141-2. doi: 10.1016/s0140-6736(81)90315-9. Lancet. 1981. PMID: 6113495 No abstract available.
Discrimination of breast cancer by anti-malignin antibody serum test in women undergoing biopsy.
Harman SM, Gucciardo F, Heward CB, Granstrom P, Barclay-White B, Rogers LW, Ibarra JA Jr. Harman SM, et al. Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2310-5. doi: 10.1158/1055-9965.EPI-04-0802. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16214910 Clinical Trial.
PURPOSE: The anti-malignin antibody serum (AMAS) test (Oncolab, Boston, MA) has been reported as 97% sensitive and 95% specific for malignancies. ...
PURPOSE: The anti-malignin antibody serum (AMAS) test (Oncolab, Boston, MA) has been reported as 97% sensitive and 95% specific for m …
Early detection and monitoring of cancer with the anti-malignin antibody test.
Abrams MB, Bednarek KT, Bogoch S, Bogoch ES, Dardik HJ, Dowden R, Fox SC, Goins EE, Goodfried G, Herrman RA, et al. Abrams MB, et al. Cancer Detect Prev. 1994;18(1):65-78. Cancer Detect Prev. 1994. PMID: 8162608
The serum anti-malignin antibody (AMA) test determines the antibody to malignin, a 10,000-Da peptide present in patients with a wide variety of cancers. ...
The serum anti-malignin antibody (AMA) test determines the antibody to malignin, a 10,000-Da peptide present in patients with …
Production of two recognins related to malignin: recognin M from mammary MCF-7 carcinoma cells and recognin L from lymphoma P3G cells.
Bogoch S, Bogoch ES. Bogoch S, et al. Neurochem Res. 1979 Aug;4(4):465-72. doi: 10.1007/BF00964641. Neurochem Res. 1979. PMID: 582619
These are very closely related in amino acid composition and in immunological reactions to the first two cancer recognins, astrocytin from human gliomas in vivo and malignin from malignant glial cells grown in vivo. Together with earlier findings, these observations sugges …
These are very closely related in amino acid composition and in immunological reactions to the first two cancer recognins, astrocytin from h …
A checklist for suitability of biomarkers as surrogate endpoints in chemoprevention of breast cancer.
Bogoch S, Bogoch ES. Bogoch S, et al. J Cell Biochem Suppl. 1994;19:173-85. J Cell Biochem Suppl. 1994. PMID: 7823589 Review.
By reference to a "checklist" of requirements for substances or processes to qualify as surrogate endpoint biomarkers, both malignin and antimalignin antibody are found to be suitable for use in breast cancer chemoprevention trials. ...
By reference to a "checklist" of requirements for substances or processes to qualify as surrogate endpoint biomarkers, both malignin …
19 results